Results 211 to 220 of about 256,370 (362)
Molecular Oncology, EarlyView.Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
The Influence of Maternal Information Sources on Infant Oral Hygiene Practices for Six-Month-Olds in South Australia: A Cross-Sectional Study. [PDF]
Int J Environ Res Public HealthTaing MW, Li W, Do LG, Ha DH.
europepmc +1 more source
Savonarole au Chat noir. Compte rendu de Léon Bloy, Chroniques et pamphlets
, 2019 Alexandre Lansmans
openalex +1 more source
Molecular Oncology, EarlyView.Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Culturally Responsive Surgical Care for Older People and Family Carers: A Dyadic Analysis. [PDF]
Nurs Health SciBonus CG, Hatcher D, Montayre J.
europepmc +1 more source
Molecular Oncology, EarlyView.Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source